Insider Transactions in Q4 2022 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 28
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
712
-0.28%
|
$11,392
$16.9 P/Share
|
Dec 28
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
501
-0.46%
|
$8,016
$16.9 P/Share
|
Dec 28
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
898
-0.25%
|
$14,368
$16.9 P/Share
|
Dec 28
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
605
-0.56%
|
$9,680
$16.9 P/Share
|
Dec 22
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
528
-1.17%
|
$8,976
$17.55 P/Share
|
Nov 30
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
33,905
-49.7%
|
$678,100
$20.59 P/Share
|
Nov 29
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,500
-2.15%
|
$30,000
$20.2 P/Share
|
Nov 29
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
307
-0.28%
|
$5,833
$19.93 P/Share
|
Nov 29
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
931
-0.26%
|
$17,689
$19.93 P/Share
|
Nov 29
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
52
-0.12%
|
$988
$19.93 P/Share
|
Nov 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
436
-0.17%
|
$8,284
$19.93 P/Share
|
Nov 28
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-6.48%
|
$210,000
$21.1 P/Share
|
Nov 23
2022
|
Michael Rice |
SELL
Bona fide gift
|
Direct |
2,750
-0.76%
|
-
|
Nov 23
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
4,500
-5.34%
|
$94,500
$21.71 P/Share
|
Nov 22
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
121
-0.27%
|
$2,420
$20.2 P/Share
|
Nov 21
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
9,500
-10.14%
|
$199,500
$21.63 P/Share
|
Nov 18
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,500
-1.58%
|
$33,000
$22.13 P/Share
|
Nov 16
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,500
-1.55%
|
$34,500
$23.21 P/Share
|
Nov 16
2022
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
3,000
-12.27%
|
$69,000
$23.85 P/Share
|
Nov 15
2022
|
Amy Du Ross Director |
SELL
Open market or private sale
|
Direct |
2,600
-12.53%
|
$62,400
$24.35 P/Share
|
Nov 14
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-8.92%
|
$480,000
$24.05 P/Share
|
Nov 10
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
38
-0.12%
|
$874
$23.16 P/Share
|
Nov 10
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
50
-0.05%
|
$1,150
$23.16 P/Share
|
Nov 10
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
91
-0.08%
|
$2,093
$23.16 P/Share
|
Nov 10
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
40
-0.11%
|
$920
$23.16 P/Share
|
Nov 10
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
107
-0.04%
|
$2,461
$23.16 P/Share
|
Nov 10
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
164
-0.05%
|
$3,772
$23.16 P/Share
|
Oct 28
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
272
-0.84%
|
$5,712
$21.76 P/Share
|
Oct 28
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
400
-1.11%
|
$8,400
$21.76 P/Share
|
Oct 14
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
236
-0.65%
|
$4,956
$21.8 P/Share
|
Oct 07
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
8,552
-6.83%
|
$188,144
$22.69 P/Share
|
Oct 03
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
1,233
-0.97%
|
$25,893
$21.95 P/Share
|